US FDA’s plan to lower nicotine levels in cigarettes faces an uncertain timeline

The US Food and Drug Administration (FDA)’s ambitious proposal to slash nicotine levels in cigarettes, making them minimally or non-addictive, unexpectedly reached a critical new milestone as it entered the White House Office of Management and Budget (OMB) for review on 10th December.

The proposed rule, which has been discussed for more than half a decade, would reduce the nicotine content in combustible cigarettes to levels so low that they became virtually nicotine-free. The intention behind this is to prevent future smokers from becoming addicted and to help current smokers quit.

Read full article
I'm already a subscriber

Antonia Di Lorenzo

Assistant news editor/senior reporter
Antonia is a member of the editorial team and holds a masters degree in Law from the University of Naples Federico II, Italy. She moved in 2013 to London, where she completed a postgraduate course at the London School of Journalism. In the UK, she worked as a news reporter for a financial newswire and a magazine before moving to Barcelona in 2019.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation